Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK | AZN | AMGN | GILD | VRTX |
| Company | Gsk Plc ADR | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 49.23 | 92.39 | 328.77 | 122.49 | 454.34 |
| High | 49.63 | 92.45 | 329.19 | 122.59 | 455.99 |
| Low | 49.07 | 91.17 | 325.01 | 121.19 | 448.52 |
| Latest | 49.63 | 91.57 | 327.64 | 121.60 | 452.13 |
| Change | +0.59 | -0.36 | +0.33 | -1.14 | -1.23 |
| % Change | +1.20% | -0.39% | +0.10% | -0.93% | -0.27% |
| Volume | 3,486,257 | 3,557,358 | 1,533,575 | 4,526,179 | 824,958 |
| 20-Day Average Volume | 3,000,374 | 4,705,508 | 2,905,764 | 6,723,889 | 1,225,153 |
| Previous Close | 49.04 | 91.93 | 327.31 | 122.74 | 453.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 48.75 | 91.26 | 326.43 | 122.36 | 453.13 |
| 20-Day Raw Stochastic | 100.00% | 59.95% | 44.94% | 37.12% | 59.81% |
| 20-Day Relative Strength | 61.53 | 56.21 | 52.24 | 48.08 | 55.15 |
| Weighted Alpha | +50.79 | +40.22 | +24.71 | +28.62 | +10.68 |
| Today's Opinion | 100% Buy | 100% Buy | 96% Buy | 48% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 80% Buy | 64% Buy | 56% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 88% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.37% since 12/24/25 | -0.95% since 12/24/25 | -1.89% since 12/24/25 | -3.24% since 12/24/25 | -2.35% since 12/24/25 |
| Low | 48.85 on 12/26/25 | 91.17 on 01/02/26 | 325.01 on 01/02/26 | 121.19 on 01/02/26 | 448.52 on 01/02/26 |
| High | 49.63 on 01/02/26 | 92.91 on 12/26/25 | 333.98 on 12/26/25 | 125.77 on 12/26/25 | 463.65 on 12/26/25 |
| 1-Month | |||||
| %Chg | +2.82% since 12/02/25 | +1.55% since 12/02/25 | -3.17% since 12/02/25 | -1.86% since 12/02/25 | +4.38% since 12/02/25 |
| Low | 47.20 on 12/09/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 433.81 on 12/10/25 |
| High | 49.63 on 01/02/26 | 93.10 on 12/23/25 | 346.38 on 12/03/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | +13.60% since 10/02/25 | +9.47% since 10/02/25 | +10.17% since 10/02/25 | +9.99% since 10/02/25 | +10.59% since 10/02/25 |
| Low | 42.85 on 10/24/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 109.66 on 10/03/25 | 400.73 on 10/06/25 |
| High | 49.63 on 01/02/26 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | +28.88% since 07/02/25 | +28.74% since 07/02/25 | +10.37% since 07/02/25 | +9.05% since 07/02/25 | -1.07% since 07/02/25 |
| Low | 35.45 on 07/17/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 49.63 on 01/02/26 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 99,963,432 | 285,116,480 | 176,250,224 | 152,281,072 | 115,026,040 |
| Shares Outstanding, K | 2,038,406 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 40,095,390,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 3,290,590,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 11,520,500,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | 2,713,320,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.45 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.48 on 10/29/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/04/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | 0.410 on 11/14/25 | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | 11/14/25 | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 11.13 | 20.24 | 15.03 | 15.04 | 29.64 |